To get the most from a GLP-1 medication for weight loss, take it exactly as prescribed, keep your follow-up visits, and pair it with the diet and activity changes your care team recommends. A simple log of doses, food (especially protein), fluids, side effects and weight makes patterns visible and gives your prescriber something concrete to work with. No habit guarantees a result: trials show real averages, but individual outcomes vary. This guide covers what to track and how to use it.
This is general information, not medical advice.
What the medications are, and what the evidence says
GLP-1 medications act on the GLP-1 receptor, which helps regulate appetite and food intake; they also slow stomach emptying (Wegovy prescribing information, sections 12.1 and 7.2). The ones labeled for weight management in the US are Wegovy (semaglutide, as a weekly injection or a daily tablet), Zepbound (tirzepatide), Saxenda (liraglutide) and, since April 2026, the daily tablet Foundayo (orforglipron) (Foundayo prescribing information); Ozempic, Mounjaro and Victoza are labeled for type 2 diabetes. A fuller comparison is in our medication guide.
Across randomized trials, people on GLP-1 drugs lost more weight than people on placebo. A 2025 meta-analysis of 47 trials found an average of 4.57 kg more weight loss than placebo (Diabetes Care), and a 2023 meta-analysis in adults without diabetes found 5.3 kg more (Am J Clin Nutr). Individual drugs differ: on the labels, Wegovy 2.4 mg averaged -14.9% at 68 weeks versus -2.4% on placebo, and Zepbound 15 mg averaged -20.9% at 72 weeks versus -3.1% (Wegovy, Zepbound). Those are group averages from trials that also included diet and activity support.
Why tracking helps
A log won’t make the drug work better, but it helps you and your prescriber see what is happening. A Cleveland Clinic study of 3,389 adults with obesity prescribed semaglutide or liraglutide found long-term weight change varied with the drug, the reason it was prescribed, the dose and how consistently people stayed on it (Cleveland Clinic newsroom). Dose, schedule and persistence are exactly the things a log records.
What to track:
- Injection day, dose and site. Missed-dose rules are specific; for Wegovy injection, a missed dose is taken if the next one is more than 2 days away, and after two or more missed doses the label says to restart escalation at a lower dose (Wegovy label, section 2.4).
- Food and protein. Cleveland Clinic advises prioritizing protein and working with a dietitian on how much (Cleveland Clinic).
- Fluids. Dehydration from vomiting or diarrhea can lead to kidney injury, according to the Wegovy label (section 5.5).
- Side effects, with timing and severity.
- Weight, measured the same way each week, and perhaps a measurement or how clothes fit.
Setting up a routine that lasts
- Start small. In week one, log only your injection and fluids.
- Add meals gradually. One meal a day is enough to begin with. Quick methods (re-using recent meals, barcodes, short descriptions) help when appetite is low.
- Review weekly, not daily. Day-to-day weight and appetite swing; a weekly view shows the direction.
- Bring the log to visits. It gives your prescriber specifics about dose steps and symptoms.
Mingo is a GLP-1 tracker for iPhone and Android where you can log shots and doses, food and protein, side effects and weight in one place. It doesn’t replace your doctor or give medical advice. Get the app, or compare features in our guides to food trackers with GLP-1 support and calorie counting on a GLP-1.
Side effects and how to handle them
Digestive effects are the most common. In the Wegovy weight-management trials, nausea was reported by 44% of people on 2.4 mg weekly versus 16% on placebo, diarrhea by 30% versus 16%, vomiting by 24% versus 6% and constipation by 24% versus 11% (Wegovy label, Table 3). Cleveland Clinic suggests smaller meals, eating slowly, limiting fatty, sugary or spicy foods, and staying hydrated (Cleveland Clinic). Severe or persistent symptoms, severe abdominal pain, or signs of an allergic reaction should be reported to your prescriber. The full list is in GLP-1 side effects: what to expect and how to manage them.
Habits that support the medication
The WHO’s 2025 guideline says medication alone won’t solve obesity and that intensive behavioral support, such as structured healthy diet and physical activity, may be offered with GLP-1 therapy, based on low-certainty evidence that it may improve outcomes (WHO). Practical pieces:
- Protein and regular meals. Don’t skip meals because you aren’t hungry. Ask a dietitian how much protein suits you.
- Strength training and aerobic activity. Cleveland Clinic says exercise helps prevent muscle loss while on semaglutide-type medicines and suggests combining strength and aerobic work, with about 150 minutes of moderate activity a week as an example target. Start gently in the first weeks (Cleveland Clinic).
- Sleep, stress and routine. They affect appetite and how you feel; tracking mood alongside meals can show links.
Plateaus and weight regain
Weight can level off for stretches. A plateau is something to discuss with your prescriber, who can review your dose, your habits and your health; don’t increase a dose on your own.
Regain after stopping is well documented. In the STEP 1 extension, people who stopped semaglutide 2.4 mg after 68 weeks (average loss 17.3%) regained 11.6 percentage points in the following year, about two-thirds of what they lost (Diabetes, Obesity and Metabolism). In the Zepbound label’s withdrawal study, people moved to placebo after 36 weeks gained 14.0% on average over the next 52 weeks, while those who continued lost a further 5.5% (Zepbound label, Table 6). If you plan to stop or can’t continue, talk with your prescriber first and keep tracking.
Protect your data
Weight, medication and eating habits are sensitive. Before you use any tracker, read how it handles your data: what stays on your device, what is sent to servers, whether it can be exported or deleted, and whether it’s shared.
Daily habits that keep the log going
Pick a regular time to log, such as after dinner. Notice trends rather than single slips. If a week gets missed, restart with the injection and fluids and add the rest back.
Mastery isn’t about perfection. It’s about coming back to the log.
Key takeaways
- Take the medication as prescribed and keep follow-ups; ask before changing a dose.
- A log of doses, protein, fluids, side effects and weight makes patterns visible.
- Trial results are averages; your own result depends on drug, dose, duration and habits.
- Weight tends to return after stopping, so plan the long-term with your prescriber.
- Pair the drug with diet and activity advice, as the labels and the WHO describe.
Frequently asked questions
What is GLP-1 weight loss therapy?
It is treatment with a medicine that activates the GLP-1 receptor (tirzepatide also the GIP receptor) alongside a reduced-calorie diet and more physical activity. Wegovy (injection or tablet), Zepbound, Saxenda and Foundayo are the US-labeled options for weight management.
How do I track my weight loss progress?
Record weight the same way each week, along with injection day and dose, side effects, food with protein, and fluids. Look at the trend over several weeks rather than single readings.
Are there side effects with GLP-1 medications?
Yes. Nausea, diarrhea, vomiting and constipation are the most common, mainly while doses are rising. Report severe or lasting symptoms to your prescriber.
How can I maximize weight loss results?
Take the medicine as prescribed, keep appointments, eat enough protein and drink enough fluids, stay active in a way your care team approves, and keep a log. No approach guarantees a particular result.
Is GLP-1 treatment worth the cost?
That depends on your health, coverage and goals, and prices change often. Discuss costs and alternatives with your prescriber and pharmacist; the WHO notes cost and access as reasons its recommendation is conditional.
